Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Lidocaine + ibuprofen** is a nonspecific two-active analgesic combination that may refer either to separate co-administration of lidocaine and ibuprofen or to a compounded topical preparation containing both agents. Lidocaine is an amide local anesthetic that inhibits voltage-gated sodium-channel-dependent nerve impulse conduction, producing local analgesia or anesthesia. Ibuprofen is a nonsteroidal anti-inflammatory drug that reversibly inhibits cyclooxygenase enzymes, reducing prostaglandin production and thereby relieving pain and inflammation. A compounded topical cream containing ibuprofen 10% and lidocaine hydrochloride 5% has been described for localized painful inflammatory conditions, and a clinical study has evaluated a lidocaine patch plus ibuprofen for acute musculoskeletal pain. ([bayviewrx.com](https://www.bayviewrx.com/formulas/Ibuprofen-10-Lidocaine-HCl-5-Topical-Cream-Osteoarthritis-Neuropathic-Pain-Tendinitis-Bursitis-Sprains-and-Strains))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine + ibuprofen.